The Statista dossier
  • Detailed references
  • Editorially prepared
  • Download as PDF / PPT

Statista dossier about the state of cancer treatment and the oncology market

This dossier presents key facts and figures about the global and U.S. cancer treatment situation and the oncology market. This document provides a closer look on the market, on companies, top products, research and development, treatment types, etc.

Table of contents

  • 1. Cancer facts
    • Global death rate - leading causes 2016

    • Cancer deaths worldwide by major type 2016

    • U.S. Americans with a history of cancer living 2004-2016

    • Number of new cancer cases in U.S. from 1999 to 2014

    • Deaths by cancer in the U.S. 1950-2015

  • 2. Oncology market
    • Global oncology costs 2010-2017

    • Expenditure and growth worldwide in oncology market 2012-2022

    • Share of oncology market spending worldwide by region 2010 vs 2016

    • Oncology spending worldwide by region 2015 vs. 2020

    • Oncology spending in selected developed countries 2015

    • Oncology spending as share of pharmaceutical spending by country 2015

  • 3. Companies
    • Global oncology revenue by top ten pharmaceutical companies 2017 and 2024

    • Global top pharmaceutical companies by oncology market share 2017 and 2024

    • Revenue share of Roche's Pharmaceuticals division by therapy area 2013-2017

    • Percentage of Novartis pharmaceuticals revenue by therapy area 2017

    • U.S. venture investments in oncology companies 2006-2017

    • U.S. oncology company IPO money raised 2006-2017

  • 4. Cancer drugs
    • Top 5 worldwide oncology products by revenue 2017 and 2024

    • Top 5 worldwide oncology products by market share 2017 and 2024

    • Availability of new cancer drugs by country as of 2017

    • Top U.S. oncology products by revenue in 2016

    • Monthly costs of select new cancer drugs 2016

  • 5. Research and development
    • FDA on breakthrough therapy requests by therapy area 2017

    • FDA on breakthrough therapy requests granted by therapy area 2017

    • Distribution of late phase oncology pipeline in 2017 by type

    • NDA/BLA filing to FDA approval times for new drugs in select disease areas 2006-2015

    • Number of cancer drugs in development in the U.S. 2005-2018

    • U.S. development Phase success rates for oncology and non oncology drugs 2006-2015

    • Cancer: 5-year survival rates in the U.S. by ethnic group 1975-2013

    • Leukemia survival rates prior and after introduction of Imatinib

  • 6. Immuno-oncology
    • Distribution of cancer immunotherapies by technology 2015

    • Global cancer immunotherapy sales 2014 and 2021 forecast

    • Global cancer immunotherapy sales share by type 2014 and 2021 forecast

    • Number of cancer immunotherapy companies by country of origin 2015

    • Global cancer immunotherapy sales share by type 2021 forecast

  • 7. Treatment types
    • Distribution of treatment types for female breast cancer by stage 2013

    • Distribution of treatment types for prostate cancer 2010-2012

    • Distribution of treatment types for colon cancer by stage 2013

    • Distribution of treatment types for lung cancer in the U.S. 2013

    • Distribution of treatment types for non-Hodgkin lymphoma 2013

  • 8. Physicians and patients
    • Number of oncology specialty physicians in the U.S. 2016

    • Distribution of U.S. oncology practices by size and setting 2016

    • Number of hours U.S. oncologists spend a week seeing patients 2018

    • Number of minutes U.S. oncologists spend with each patient 2018

    • Inpatient average length of stay in U.S. hospitals by cancer type 2008-2016

    • U.S. cancer patients who used complementary or alternative medicine 2015, by type

  • Language: English
  • Released: April 2017
More than 7,500
Recommended studies and dossiers
Show more
Recent studies and dossiers
You may also be interested in...
Statista is a great source of knowledge, and pretty helpful to manage the daily work.

Christof Baron about Statista CEO, MindShare Germany

Any more questions?

Get in touch with us quickly and easily. We are happy to help!